PubAg

Main content area

Supplementation of long chain n-3 polyunsaturated fatty acids increases the utilization of lycopene in cultured airway epithelial cells

Author:
SAEDISOMEOLIA, AHMAD, WOOD, LISA G., GARG, MANOHAR L., GIBSON, PETER G., WARK, PETER A.B.
Source:
Journal of food lipids 2008 v.15 no.4 pp. 421-432
ISSN:
1065-7258
Subject:
anti-inflammatory activity, antioxidants, cell membranes, docosahexaenoic acid, eicosapentaenoic acid, epithelial cells, gas chromatography, high performance liquid chromatography, lipid peroxidation, lycopene, models, omega-3 fatty acids, respiratory tract diseases
Abstract:
Increased content of long chain n-3 polyunsaturated fatty acids (LCn-3PUFA) in cellular membranes results in increased susceptibility to lipid peroxidation. Antioxidants such as lycopene prevent lipid peroxidation and oxidative degradation. The aim of this study was to determine the effects of LCn-3PUFA supplementation on lycopene levels in cultured airway epithelial cells. Airway epithelial cells (Calu-3) were incubated with eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), lycopene-DHA and lycopene-EPA for 24 h. The fatty acid incorporation into the cells was analyzed using gas chromatography. Intracellular lycopene concentration was determined using high-performance liquid chromatography. It was found that EPA (10.6%) and DHA (19.5%) were incorporated into Calu-3 cells. It was also found that increased incorporation of DHA (and to a lesser extent EPA) resulted in decreased intracellular lycopene levels. These findings suggest that supplementation with LCn-3PUFA increases the cellular need for antioxidants. Increasing the proportion of long chain n-3 polyunsaturated fatty acids (LCn-3PUFA) in airway cell membranes leads to increased utilization of a potent antioxidant, lycopene. This increased utilization of lycopene is probably due to the increased susceptibility of LCn-3PUFA to oxidative damage. The interaction between lycopene and LCn-3PUFA has important implications for both in vivo and in vitro models of respiratory diseases and suggests that co-supplementation of antioxidants with LCn-3PUFA is essential to maximize any potential anti-inflammatory effect.
Agid:
4046971